Replies to post #817720 on NorthWest Biotherapeutics Inc (NWBO)

[AllSheWrote]

Was thinking more like jettisoning L to pursue other endeavors announcement?

I think that's very possible. On the other hand, LP is no spring chicken so transitioning the business model may not be in the cards for her. She may just fold up shop. But I think it depends on the prospects for Advent. If Advent can become a self-sufficient CDMO and she can hand off the reins, that would be the most likely new business model, imo.

There will be some pretty significant lawsuits that come out of this disaster. That's going to tie up her retirement. I'm still amazed that there's anyone still invested in this nonsense. It's really incredible that at this point in the game there are still folks who cannot see the hand they've been dealt.

[exwannabe]

Doubt they’re capable at this point of a big dilution event given the level of distrust and lack of trading. Was thinking more like jettisoning L to pursue other endeavors announcement?

I expect -L to just fade to black over the years. A couple small inexpensive trials will be started with Roswel tech / Direct to keep retail engaged.

And yes, they will focus on "other endeavors", but a gradual shift in messaging is what will be seen.

[Investor082]

Good point. I agree no one in their right mind would give them a bunch of funding at once. The financiers want to dump these shares as quickly as possible so doing it in small chunks as they have been doing over the years makes the most sense.

Well, if they announce any other initiative outside L (conditional) approval, it’s going to be a train wreck. A positive regulatory decision, even if its conditional, will give them some breathing room to continue to trap more bag holders by building false expectations around commercialization.

Either way, LP’s financiers are going to have an extended party.